Dear Friends,
I am conducting some research for a paper exploring the potential for large-scale securitization of pharmaceutical/biotech IP and their role in forming an alternative funding method for small to mid-cap pharma.
If anyone works (or knows someone who works) in/with securities, derivatives, structured products and special purpose vehicles I would greatly appreciate the chance to PM them or have them PM to gather more information.
If privacy is a concern for anyone, names (and if need be, firm names) will be omitted.
Thank you in advance
Bump
I follow esoteric ABS on the banking side. We bank a healthcare company and they're in the market once every 2 or so years
Mind if I PM you?
not at all. lets chat
hey, are you still in the space? I'm an An1 in securitization and am thinking of lateraling to IB as it seems like there are no transferrable skills to the buyside (I don't have a quant/math/programming background so all the structuring/break-even analysis, Intex, etc. is done by someone else). I also focus on prime assets (I'm in Canada), so I don't feel like I'm learning too much. I've tried to dig around for Intex courses online or other securitization cashflow modelling courses but have no luck. If you have any resources to share, or have advice on what I should do, I'd appreciate it!
This is probably too late to be helpful, and I don't know that my experience is directly relevant, but I have some experience with royalty financing funds if that is at all relevant? I interviewed with one of the bigger royalty funds several years back when they were first emerging (final round but no offer), and a couple portfolio companies of the fund I worked at did some royalty financing deals. My takeaway back then 2011-2014 is that they were comparable to venture debt in terms of total cost of capital, haven't seen as many deals in the current market, maybe bc capital is just more abundant now.
Anyway I think it's a pretty interesting topic intellectually and I'm sure there are some cool opportunities out there, so would love to hear what you found
thanks for the input but unfortunately the paper has already been finished! If something similar comes up again I'll keep you in mind.
Ratione sequi eaque atque quia. Tenetur error sapiente rem eius possimus nemo qui.
Tempora tenetur id quia numquam. Beatae provident consequatur quisquam ut qui corrupti et facilis. Aut voluptatem fugiat saepe officia excepturi ex.
Atque praesentium pariatur fugiat veniam sint. Aperiam reprehenderit voluptatem eligendi inventore voluptatem. Enim voluptatum culpa voluptate. Incidunt sint vero sed quia occaecati fugiat et.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...